Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 148,580 | 142,580 | 57,993 | 54,269 | 54,141 |
| Marketable Securities | 7,330 | 11,940 | 22,316 | 42,670 | 32,178 |
| Receivables | 440,120 | 423,170 | 413,838 | 385,555 | 361,876 |
| Inventories | 459,870 | 432,400 | 386,742 | 362,964 | 306,558 |
| Other current assets | 205,770 | 188,980 | 183,132 | 155,125 | 154,451 |
| TOTAL | $1,261,670 | $1,199,070 | $1,064,021 | $1,000,583 | $909,204 |
| Non-Current Assets | |||||
| PPE Net | 796,610 | 750,110 | 706,515 | 652,398 | 608,014 |
| Investments And Advances | 85,370 | 87,290 | 66,239 | 81,777 | 91,041 |
| Other Non-Current Assets | 319,660 | 312,110 | 338,580 | 319,388 | 320,104 |
| TOTAL | $1,201,640 | $1,149,510 | $1,111,334 | $1,053,563 | $1,019,159 |
| Total Assets | $2,229,230 | $2,125,100 | $1,967,807 | $1,857,831 | $1,742,052 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 67,070 | 66,510 | 98,878 | 213,287 | 210,537 |
| Accrued Expenses | 224,190 | 245,910 | 229,594 | 83,075 | 107,781 |
| Other current liabilities | 4,660 | 6,270 | 6,292 | 5,463 | 4,892 |
| TOTAL | $365,190 | $380,210 | $808,011 | $667,733 | $673,475 |
| Non-Current Liabilities | |||||
| Long Term Debt | 551,190 | 554,880 | 46,325 | 49,855 | 0 |
| Other Non-Current Liabilities | 72,500 | 70,140 | 69,205 | 58,575 | 58,995 |
| TOTAL | $681,720 | $683,050 | $173,564 | $168,405 | $118,970 |
| Total Liabilities | $1,046,920 | $1,063,280 | $981,575 | $836,138 | $792,445 |
| Shareholders' Equity | |||||
| Common Shares | 1,950 | 1,950 | 1,956 | 1,956 | 1,956 |
| Retained earnings | 816,530 | 760,360 | 706,542 | 707,641 | 622,591 |
| Other shareholders' equity | -86,170 | -69,050 | -58,822 | -44,374 | -50,069 |
| TOTAL | $1,182,310 | $1,061,810 | $986,232 | $1,021,693 | $949,607 |
| Total Liabilities And Equity | $2,229,230 | $2,125,090 | $1,967,807 | $1,857,831 | $1,742,052 |